by Abdelhamid | May 31, 2024
To ensure productive collaboration, the fellows involved in the CRUCIAL project hold regular meetings.
These meetings are opportunities to discuss multiple topics among which we find work progress, knowledge divulgation and research and analyses (capillary density) between groups.
So far, they met on:
- October 20, 2021
- July 14, 2022
- October 13, 2022
- November 23, 2022
- December 13, 2022
- December 20, 2022
by Abdelhamid | May 31, 2024
Hosted by INLECOM in Dublin, the meeting was attended representatives from all partner organizations. Participants presented their work, discussed results, and engaged in productive dialogue.
A portion of the meeting was dedicated to reflect on how to maximize the CRUCIAL project’s output and ensure its long-term legacy. Among other initiatives, the partners intend to organize events post-project to continue these discussions.
More information will be provided in the future.
by Abdelhamid | May 31, 2024
To maximize the impact and output of the CRUCIAL project, INLECOM proposed organizing a specialized workshop on the 8 May 2023, aimed at enhancing the consortium partners’ understanding of patents.
During this workshop, INLECOM shared their extensive expertise, informing participants about what innovations and discoveries can be patented. They also covered various patent strategies and approaches, providing valuable insights into the patenting process and how to effectively protect intellectual property within the scope of the project.
by Abdelhamid | May 31, 2024
The CRUCIAL consortium held its third General Assembly on the 8 and 9 February 2023.
The meeting was hosted by KU Leuven and was the first face to face meeting for the consortium since the kick off of the project in February 2020.
Representatives from all partner organizations attended and were able to give presentations of their work and discuss results.
by Abdelhamid | May 31, 2024
The CRUCIAL consortium held its second General Assembly on February 10, 2022.
The meeting was held virtually once again, during which all consortium representatives discussed and decided to extend the project’s duration by one year.
The COVID-19 pandemic had a particularly significant impact on CRUCIAL compared to other research projects. This was largely due to the nature of our studies, which involve conditions that increase vulnerability to COVID-19, and because many of the physicians involved were reassigned to patient care during the pandemic.
This project has received funding from the SESAR Joint Undertaking under the European Union’s Horizon 2020 research and innovation programme under grant agreement No 848109.